# OnCo record hilo (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/hilo/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "hilo", "NCT00415233" ;
  schema:name "HiLo"@en ;
  schema:description "Showed a third of the usual radioactive iodine dose ablates the thyroid remnant just as well, with fewer side effects and less time in isolation."@en ;
  schema:url <https://onco.cc/trials/hilo/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00415233>, <https://www.nejm.org/doi/full/10.1056/NEJMoa1109589> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2006-11" ;
  onco:cancers <https://onco.cc/cancers/thyroid/> ;
  onco:technologies <https://onco.cc/technologies/radioiodine-therapy/> ;
  onco:institutions <https://onco.cc/institutions/cruk/> .
